SAMSARA BIOCAPITAL, LLC
Adviser information for SAMSARA BIOCAPITAL, LLC last updated from Form ADV on March 31st, 2024. Select data displayed; additional Form ADV, Form D, Form 13F and other data is available from the Fincoded API.
Advisory Business
Type of Organization | Limited Liability Company |
---|---|
Fiscal Year End | DECEMBER |
Legal Location | Delaware, United States |
Employees
Total Number of Employees | 26 |
---|---|
Investment Advisory/Research | 16 |
Registered Broker-Dealer Representatives | 0 |
Registered State Investment Advisers | 0 |
Licensed Agents of an Insurance Company | 0 |
No. of Firms/People that Solicit Clients | 0 |
RAUM
Provides Management of Securities Portfolios | Yes |
---|
Type | Accounts | RAUM |
---|---|---|
Discretionary | 3 | $1.6B |
Non-Discretionary | 0 | $0 |
Total | 3 | $1.6B |
Clients
Type | Number | RAUM |
---|---|---|
Individuals | 0 | $0 |
HNW Individuals | 0 | $0 |
Banking or thrift institutions | 0 | $0 |
Investment companies | 0 | $0 |
Business development companies | 0 | $0 |
Pooled investment vehicles | 3 | $1.6B |
Pension and profit sharing plans | 0 | $0 |
Charitable organizations | 0 | $0 |
State or municipal gov entities | 0 | $0 |
Other investment advisers | 0 | $0 |
Insurance companies | 0 | $0 |
Sovereign wealth funds and foreign official institutions | 0 | $0 |
Corporations or other businesses | 0 | $0 |
Other | 0 | $0 |
Type | Number |
---|---|
No. of Non-RAUM Clients | 0 |
No. of Non-U.S. Clients | 33 |
Services
Advisory Services | Portfolio management for pooled investment vehicles |
---|---|
Compensation | % of AUMPerformance-based fees |
Principal Office
628 MIDDLEFIELD ROADPALO ALTO
CA
United States
Monday - Friday, 8:00 AM TO 5:00 PM
Tel: 650-285-4270, Fax: (425) 328-3517
Chief Compliance Officer
ABRAR A. HUSSAIN
CHIEF COMPLIANCE OFFICER
628 MIDDLEFIELD ROAD
PALO ALTO
CA
United States
Tel:
650-285-4270
A****@*************M
(Full email address available in API data)
Regulatory Contact
SRINIVAS AKKARAJU
MANAGING MEMBER
628 MIDDLEFIELD ROAD
PALO ALTO
CA
United States
Tel:
650-285-4270
S****@*************M
(Full email address available in API data)
Industry Affiliates
565 SPV GP I, LLC | Sponsor, GP, manager of pooled investment vehicles |
SAMSARA BIOCAPITAL GP, LLC | Sponsor, GP, manager of pooled investment vehicles |
SMSR B1 GP, LLC | Sponsor, GP, manager of pooled investment vehicles |
Private Funds
Name | Type | Assets $USD | Min Investment $USD | No. Owners |
---|---|---|---|---|
565 SPV I, L.P. | Venture Capital Fund | $0.0M | $0.0M | 8 |
SAMSARA BIOCAPITAL, L.P. | Venture Capital Fund | $1,622.8M | $0.1M | 154 |
SMSR B1, L.P. | Venture Capital Fund | $120.7M | $0.0M | 1 |
Control Persons
Name | Type | Entity | Title | Since | Ownership |
---|---|---|---|---|---|
AHMAD, MIRAN, NASRUDDIN | Individual | – | CHIEF FINANCIAL OFFICER | 01/2023 | < 5% |
AKKARAJU, SRINIVAS | Individual | – | MANAGER OF SAMSARA BIOCAPITAL, LLC | 09/2016 | > 75% |
DYBBS, MICHAEL, PHILIP | Individual | – | PARTNER | 02/2017 | < 5% |
HUSSAIN, ABRAR, AHMED | Individual | – | GENERAL COUNSEL AND CHIEF COMPLIANCE OFFICER | 01/2023 | < 5% |
No. Employees, Historic
RAUM, Historic
No. Clients, Historic
Holdings
From latest 13F, filed August 14th, 2024 for period ending June 30th, 2024
Name | Class | Value $USD | # Shares | Private Fund |
---|---|---|---|---|
ABIVAX SA | SPONSORED ADS | 11M | 850K | – |
ACELYRIN INC | COM | 11M | 3M | – |
ACLARIS THERAPEUTICS INC | COM | 766K | 696K | – |
ALLAKOS INC | COM | 172K | 172K | – |
ALLOVIR INC | COM | 60K | 82K | – |
ARCELLX INC | COMMON STOCK | 25M | 454K | – |
AVADEL PHARMACEUTICALS PLC | COM SHS | 14M | 968K | – |
BOLT BIOTHERAPEUTICS INC | COM | 787K | 1M | – |
CARGO THERAPEUTICS INC | COM | 73M | 4M | – |
CONTINEUM THERAPEUTICS INC | CL A | 10M | 589K | – |
DAY ONE BIOPHARMACEUTICALS I | COM | 3M | 196K | – |
ELIEM THERAPEUTICS INC | COM | 23M | 3M | – |
GOSSAMER BIO INC | COM | 6M | 6M | – |
HILLEVAX INC | COM | 12M | 799K | – |
IGM BIOSCIENCES INC | COM | 1M | 155K | – |
IMMATICS N.V | SHS | 2M | 198K | – |
INOZYME PHARMA INC | COM | 7M | 2M | – |
IO BIOTECH INC | COM | 4M | 4M | – |
JANUX THERAPEUTICS INC | COM | 2M | 45K | – |
JASPER THERAPEUTICS INC | COM NEW | 12M | 525K | – |
KRONOS BIO INC | COM | 97K | 78K | – |
LEAP THERAPEUTICS INC | COM NEW | 5M | 2M | – |
LENZ THERAPEUTICS INC | COM | 21M | 1M | – |
LYRA THERAPEUTICS INC | COM | 769K | 3M | – |
MINERALYS THERAPEUTICS INC | COM | 59M | 5M | – |
NEUROGENE INC | COM | 46M | 1M | – |
NKARTA INC | COM | 22M | 4M | – |
NUVATION BIO INC | *W EXP 07/07/202 | 21K | 133K | – |
PRIME MEDICINE INC | COM | 3M | 540K | – |
RHYTHM PHARMACEUTICALS INC | COM | 7M | 173K | – |
SCHOLAR ROCK HLDG CORP | COM | 57M | 7M | – |
SURROZEN INC | *W EXP 08/01/203 | 2K | 100K | – |
SUTRO BIOPHARMA INC | COM | 6M | 2M | – |
SYROS PHARMACEUTICALS INC | COM NEW | 9M | 2M | – |
TANGO THERAPEUTICS INC | COM | 5M | 630K | – |
TERNS PHARMACEUTICALS INC | COM | 1M | 202K | – |
VERONA PHARMA PLC | SPONSORED ADS | 5M | 348K | – |
VIRACTA THERAPEUTICS INC | COM | 375K | 690K | – |
VTV THERAPEUTICS INC | CL A NEW | 4M | 207K | – |
ZYMEWORKS INC | COM | 9M | 1M | – |